ABALLI JOHN - Insider Non-Derivative Transactions at EXAGEN INC. (XGN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on May 16, 2024, ABALLI JOHN's relationship to EXAGEN INC. (XGN) is Director,Officer (President and CEO), and currently has 40,401 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other XGN insiders.

Data Source: SEC.
ABALLI JOHN - Insider Non-Derivative Transactions of XGN Common Stock
ABALLI JOHN - Insider Non-Derivative Transactions at XGN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
May 17, 2024 P -- (Common Stock) 40401 1.92 40401
Mar 1, 2024 Acquisition -- (Common Stock) 9804 1.91 600788
Feb 21, 2024 Acquisition -- (Common Stock) 175000 0 590984
Oct 18, 2023 Sell -- (Common Stock) 33819 1.75 415984
Sep 1, 2023 Acquisition -- (Common Stock) 9803 2.14 449803